Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.32 CAD | -1.54% | -3.03% | -17.95% |
May. 15 | Microbix Biosystems Up More Than 10% As Q2 Profit Grows On Higher Revenues; Says Stage Set For Record FY | MT |
May. 15 | Transcript : Microbix Biosystems Inc., Q2 2024 Earnings Call, May 15, 2024 |
Chart calendar Microbix Biosystems Inc.
Upcoming events on Microbix Biosystems Inc.
Past events on Microbix Biosystems Inc.
2024-05-15 10:00 am | Q2 2024 Earnings Call |
2024-05-15 07:59 am | Q2 2024 Earnings Release |
2024-04-16 10:30 am | Bloom Burton & Co. Healthcare Investor Conference |
2024-03-27 01:00 pm | Annual General Meeting |
2024-03-12 | EUROGIN International Multidisciplinary HPV Congress |
2024-02-14 10:00 am | Q1 2024 Earnings Call |
2024-02-14 07:13 am | Q1 2024 Earnings Release |
2024-01-03 11:00 am | Q4 2023 Earnings Call |
2023-12-21 07:32 am | Q4 2023 Earnings Release |
2023-11-17 10:00 am | JW Marriott Turnberry Florida Capital Conference |
2023-11-17 10:00 am | Business Update Call |
2023-09-28 | Muskoka Capital Conference |
2023-09-06 01:00 pm | Planet MicroCap Showcase |
2023-08-14 11:00 am | Q3 2023 Earnings Call |
2023-08-10 07:57 am | Q3 2023 Earnings Release |
2023-07-22 | American Association of Clinical Chemistry Conference |
2023-06-14 | American Society of Microbiology Conference |
2023-05-16 11:00 am | Q2 2023 Earnings Call |
2023-05-11 07:30 am | Q2 2023 Earnings Release |
2023-04-26 11:30 am | Bloom Burton & Co Healthcare Investor Conference |
Annual results
Fiscal Period | September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 8,27 9,49 -12.77% | 14,5 15,3 -5.31% | 14,0 15,3 -8.42% | 12,4 12,7 -2.22% | 18,5 |
EBITDA Million USD | Released Forecast Spread | 0,00 | -0,70 1,73 -140.53% | 4,41 4,50 -2.2% | 2,68 3,09 -13.47% | -1,18 -0,45 -165.53% | 3,60 |
EBIT | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 2,52 3,06 -17.71% | 1,37 2,16 -36.48% | 0,00 0,00 - | 0,00 |
Net income Million USD | Released Forecast Spread | 0,02 | 0,00 0,00 - | 2,52 3,06 -17.79% | 1,31 2,18 -39.88% | 0,00 0,00 - | 0,00 |
EPS CAD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,03 0,03 0% | 0,01 0,02 -35% | 0,00 -0,02 - | 0,02 |
Announcement Date | 20/12/19 | 18/12/20 | 23/12/21 | 22/12/22 | 21/12/23 | - |
Quarterly results
Fiscal Period | September | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 3,75 4,68 -19.84% | 3,93 4,26 -7.88% | 3,18 4,02 -20.85% | 1,86 2,85 -34.68% | 3,13 3,07 1.92% | 4,13 3,56 16.08% | 3,21 3,57 -10.05% | 6,20 6,07 2.26% | 4,14 3,76 10.07% | 4,04 | 4,12 |
EBITDA Million USD | Released Forecast Spread | 0,92 1,74 -47.14% | 0,84 0,68 23.34% | 0,03 0,62 -95.92% | -0,72 0,23 -413.79% | 0,32 -0,15 310.28% | -0,27 0,22 -221.82% | -0,51 0,22 -329.11% | 2,18 2,62 -16.9% | 0,63 0,07 757.51% | 0,37 | 0,37 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,56 1,39 -59.55% | 0,50 0,44 14.98% | -0,97 0,56 -271.85% | 0,02 0,64 -96.31% | |||||||
Net income Million USD | Released Forecast Spread | 0,56 1,40 -59.78% | 0,50 0,44 13.93% | -0,97 0,57 -270% | 0,02 0,64 -96.34% | |||||||
EPS CAD | Released Forecast Spread | 0,01 0,01 -58.33% | 0,00 0,00 0% | 0,00 0,01 -160% | -0,01 -0,01 -28.57% | 0,00 0,00 - | -0,01 0,00 - | 0,01 0,00 1500% | ||||
Announcement Date | 12/05/22 | 11/08/22 | 22/12/22 | 09/02/23 | 11/05/23 | 10/08/23 | 21/12/23 | 14/02/24 | 15/05/24 | - | - |
2024-06-30 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
Past sector events for Microbix Biosystems Inc.
2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | NUVATION BIO INC.: Q1 2024 Earnings Release |
2024-05-14 07:30 am | ABSCI CORPORATION: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MBX Stock
- Calendar Microbix Biosystems Inc.